316 related articles for article (PubMed ID: 33628339)
1. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients.
Abdelbasset WK; Nambi G; Elsayed SH; Moawd SA; Ibrahim AA; Verma A; Tantawy SA; Kamel DM; Saleh AK; Aldhafian OR; Nwihadh NB
Dis Markers; 2021; 2021():8866093. PubMed ID: 33628339
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge.
Kamimura H; Sato T; Natsui K; Kobayashi T; Yoshida T; Kamimura K; Tsuchiya A; Murayama T; Yokoyama J; Kawai H; Takamura M; Terai S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572604
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of sarcopenia in patients with cirrhosis.
Montano-Loza AJ
World J Gastroenterol; 2014 Jul; 20(25):8061-71. PubMed ID: 25009378
[TBL] [Abstract][Full Text] [Related]
4. The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study.
Lattanzi B; Bruni A; Di Cola S; Molfino A; De Santis A; Muscaritoli M; Merli M
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371806
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans.
Eslamparast T; Montano-Loza AJ; Raman M; Tandon P
Liver Int; 2018 Oct; 38(10):1706-1717. PubMed ID: 29738109
[TBL] [Abstract][Full Text] [Related]
6. Effect of a 12-week home-based exercise training program on aerobic capacity, muscle mass, liver and spleen stiffness, and quality of life in cirrhotic patients: a randomized controlled clinical trial.
Sirisunhirun P; Bandidniyamanon W; Jrerattakon Y; Muangsomboon K; Pramyothin P; Nimanong S; Tanwandee T; Charatcharoenwitthaya P; Chainuvati S; Chotiyaputta W
BMC Gastroenterol; 2022 Feb; 22(1):66. PubMed ID: 35164698
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia and chronic liver diseases.
Hsu CS; Kao JH
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia and Frailty in Cirrhosis: Assessment and Management.
Bunchorntavakul C
Med Clin North Am; 2023 May; 107(3):589-604. PubMed ID: 37001955
[TBL] [Abstract][Full Text] [Related]
9. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.
Carey EJ; Lai JC; Sonnenday C; Tapper EB; Tandon P; Duarte-Rojo A; Dunn MA; Tsien C; Kallwitz ER; Ng V; Dasarathy S; Kappus M; Bashir MR; Montano-Loza AJ
Hepatology; 2019 Nov; 70(5):1816-1829. PubMed ID: 31220351
[TBL] [Abstract][Full Text] [Related]
10. Nutrition and exercise in the management of liver cirrhosis.
Toshikuni N; Arisawa T; Tsutsumi M
World J Gastroenterol; 2014 Jun; 20(23):7286-97. PubMed ID: 24966599
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.
Kim HY; Jang JW
World J Gastroenterol; 2015 Jul; 21(25):7637-47. PubMed ID: 26167066
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Cardiac Rehabilitation for Prevention and Treatment of Sarcopenia in Patients with Cardiovascular Disease - A Retrospective Cross-Sectional Analysis.
Harada H; Kai H; Niiyama H; Nishiyama Y; Katoh A; Yoshida N; Fukumoto Y; Ikeda H
J Nutr Health Aging; 2017; 21(4):449-456. PubMed ID: 28346572
[TBL] [Abstract][Full Text] [Related]
13. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients.
Aby ES; Saab S
Clin Liver Dis; 2019 Nov; 23(4):589-605. PubMed ID: 31563213
[TBL] [Abstract][Full Text] [Related]
14. [The nutritional state and treatment in cirrhotic patients].
Shiraki M; Hanai T; Shimizu M
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(1):20-26. PubMed ID: 28070091
[No Abstract] [Full Text] [Related]
15. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia.
Mohta S; Anand A; Sharma S; Qamar S; Agarwal S; Gunjan D; Singh N; Madhusudhan KS; Pandey RM; Saraya A
Hepatol Int; 2022 Jun; 16(3):680-690. PubMed ID: 35469091
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia in Patients with Advanced Liver Disease.
Ponziani FR; Gasbarrini A
Curr Protein Pept Sci; 2018; 19(7):681-691. PubMed ID: 28462693
[TBL] [Abstract][Full Text] [Related]
17. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
[TBL] [Abstract][Full Text] [Related]
18. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
19. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.
Sinclair M; Gow PJ; Grossmann M; Angus PW
Aliment Pharmacol Ther; 2016 Apr; 43(7):765-77. PubMed ID: 26847265
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019.
Traub J; Bergheim I; Eibisberger M; Stadlbauer V
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
